Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2A type 1-J (H2AC14) is a member of the core histone H2A family, encoded by the intronless gene HIST1H2AJ on chromosome 6p22-p21.3[4][6]. Like other H2A histones, it forms part of the histone octamer around which DNA is wrapped in nucleosomes—structures fundamental to chromatin organization in eukaryotic cells[4][5][6]. Two molecules each of H2A, H2B, H3, and H4 form the nucleosome core, enabling compaction and regulation of DNA accessibility[4][5]. H2A family members are critical for genome stability, chromatin higher-order packaging, and modulation of gene transcription by modifying nucleosome dynamics and thereby impacting DNA repair, replication, and transcriptional processes[2][4]. H2A type 1-J is a canonical, replication-dependent histone lacking a polyA tail, instead terminating with a palindromic sequence[4][6]. While core histones and their variants play fundamental roles in cellular proliferation and gene regulation, to date, H2A type 1-J itself is not considered a unique therapeutic target, nor are there clinical drugs or established diagnostics directly involving this specific protein. Alterations in core histone composition can contribute to oncogenesis and chromatin-related diseases but are typically studied in the context of broad chromatin regulatory networks rather than individual canonical H2A members[2][4].
Not applicable (no specific drugs targeting H2A type 1-J; role in chromatin assembly and structure)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2A type 1-J (H2AC14).